Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma
Abstract Soluble vector family member 6 (SLC2A6) has been implicated in the aggressiveness and poor prognosis of various cancers, yet its specific role in hepatocellular carcinoma (HCC) remains to be fully elucidated. This study utilized multiple databases to investigate the relationship between SLC...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85504-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585865205907456 |
|---|---|
| author | Guohong Yan Hailian Huang Ziyan Lu Meifeng Chen Xiang Wang Pei Zhong Chongjiu Qin Shutian Mo Chuangye Han Xiaoling Luo Xinping Ye |
| author_facet | Guohong Yan Hailian Huang Ziyan Lu Meifeng Chen Xiang Wang Pei Zhong Chongjiu Qin Shutian Mo Chuangye Han Xiaoling Luo Xinping Ye |
| author_sort | Guohong Yan |
| collection | DOAJ |
| description | Abstract Soluble vector family member 6 (SLC2A6) has been implicated in the aggressiveness and poor prognosis of various cancers, yet its specific role in hepatocellular carcinoma (HCC) remains to be fully elucidated. This study utilized multiple databases to investigate the relationship between SLC2A6 expression and clinical stage, methylation status, drug sensitivity, immune infiltration, and immune checkpoint regulation. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted. Furthermore, in vitro and in vivo experiments were performed to assess the impact of SLC2A6 knockout on the proliferation, migration, invasion, and underlying mechanisms in hepatocellular carcinoma (LIHC) cells. SLC2A6 expression was significantly correlated with tumor prognosis, clinical stage, and methylation levels, and was found to influence immune cell infiltration and immune checkpoint gene expression. In LIHC, SLC2A6 was associated with key biological processes, including the cell cycle, P53 signaling, and ferroptosis. Knockdown of SLC2A6 markedly suppressed the proliferation, migration, and invasion of HCC cells, with this inhibition being closely tied to the ferroptosis pathway. SLC2A6 plays a pivotal role in the regulation of pan-cancer processes, particularly in tumor prognosis and immune-related mechanisms. In LIHC, it emerges as a potential prognostic biomarker and therapeutic target for the regulation of ferroptosis, offering new insights for targeted cancer therapies. |
| format | Article |
| id | doaj-art-ad193f8554584c9d8fd6f3647ab926fc |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-ad193f8554584c9d8fd6f3647ab926fc2025-01-26T12:26:41ZengNature PortfolioScientific Reports2045-23222025-01-0115112010.1038/s41598-025-85504-2Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinomaGuohong Yan0Hailian Huang1Ziyan Lu2Meifeng Chen3Xiang Wang4Pei Zhong5Chongjiu Qin6Shutian Mo7Chuangye Han8Xiaoling Luo9Xinping Ye10Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversitySchool of Basic Medical Sciences, Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversitySchool of Basic Medical Sciences, Guangxi Medical UniversityDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical UniversityAbstract Soluble vector family member 6 (SLC2A6) has been implicated in the aggressiveness and poor prognosis of various cancers, yet its specific role in hepatocellular carcinoma (HCC) remains to be fully elucidated. This study utilized multiple databases to investigate the relationship between SLC2A6 expression and clinical stage, methylation status, drug sensitivity, immune infiltration, and immune checkpoint regulation. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted. Furthermore, in vitro and in vivo experiments were performed to assess the impact of SLC2A6 knockout on the proliferation, migration, invasion, and underlying mechanisms in hepatocellular carcinoma (LIHC) cells. SLC2A6 expression was significantly correlated with tumor prognosis, clinical stage, and methylation levels, and was found to influence immune cell infiltration and immune checkpoint gene expression. In LIHC, SLC2A6 was associated with key biological processes, including the cell cycle, P53 signaling, and ferroptosis. Knockdown of SLC2A6 markedly suppressed the proliferation, migration, and invasion of HCC cells, with this inhibition being closely tied to the ferroptosis pathway. SLC2A6 plays a pivotal role in the regulation of pan-cancer processes, particularly in tumor prognosis and immune-related mechanisms. In LIHC, it emerges as a potential prognostic biomarker and therapeutic target for the regulation of ferroptosis, offering new insights for targeted cancer therapies.https://doi.org/10.1038/s41598-025-85504-2SLC2A6Pan-cancerHepatocellular carcinomaFerroptosisImmunity |
| spellingShingle | Guohong Yan Hailian Huang Ziyan Lu Meifeng Chen Xiang Wang Pei Zhong Chongjiu Qin Shutian Mo Chuangye Han Xiaoling Luo Xinping Ye Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma Scientific Reports SLC2A6 Pan-cancer Hepatocellular carcinoma Ferroptosis Immunity |
| title | Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma |
| title_full | Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma |
| title_fullStr | Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma |
| title_full_unstemmed | Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma |
| title_short | Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma |
| title_sort | comprehensive pan cancer analysis and functional studies reveal slc2a6 as a ferroptosis modulator in hepatocellular carcinoma |
| topic | SLC2A6 Pan-cancer Hepatocellular carcinoma Ferroptosis Immunity |
| url | https://doi.org/10.1038/s41598-025-85504-2 |
| work_keys_str_mv | AT guohongyan comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT hailianhuang comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT ziyanlu comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT meifengchen comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT xiangwang comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT peizhong comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT chongjiuqin comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT shutianmo comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT chuangyehan comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT xiaolingluo comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma AT xinpingye comprehensivepancanceranalysisandfunctionalstudiesrevealslc2a6asaferroptosismodulatorinhepatocellularcarcinoma |